Retrieving the file
Live· 4,218,906 positions deprecated· 4,218,906 deprecated· 1,284 today
Average time-to-redundancy: 11.3 months
Know before your role does.
pssst. this is to sign up for updates on the game ;)
Will AI replace Infection and Immunity Researcher jobs? · Latest report #au8mqxmz
Your job has an expiration date
May 14, 2030
In 3 years, 7 monthsYour pipetting precision is no match for a high-throughput liquid handler.
Grant-chasing expert with a talent for precise centrifugation.
Check another roleComment your opinionor JOIN THE RESISTANCE!
One human is building a game about fighting back.
Systemic immunity analysis at machine speed.
wheee!you▸ IMMUNOGEN-X 9000▸ RARITY · RARE▸ DEPRECATION IN 3 YEARS, 7 MONTHSAI's Special Power
automates immune profiling across thousands of samples
Conducts longitudinal immune profiling, manages biobanks, performs flow cytometry, and drafts grant applications to sustain lab funding.
The one thing AI can't do
You can still intuit the subtle biological anomalies within a messy, contaminated sample set.
Your enemy, your name, your date. Post it.
Step by step, from the first quiet change to Deprecation Day.
Day 6
AI models ingest existing sequencing data to predict immune response patterns without your manual interpretation.
Month 9
Robotic fluidic systems take over manual plating and dilution steps with higher precision than human hands.
Month 18
Vision-guided flow cytometry platforms autonomously identify cellular populations and flag anomalies in real-time.
Year 2.4
Natural language agents generate grant proposals by synthesizing your past lab outcomes and current literature trends.
Year 3.6 · D-Day
The lab facility transitions to full autonomy with remote oversight, rendering onsite research presence entirely optional.
What you cost, what the machine costs, and what you get on the way out.
Per year
Savings: 95.1%
78%
Paper rejection rate
450
Pipette strokes hourly
Excessive
Coffee consumption levels
Your severance
A lifetime subscription to a premium academic journal.
Discussion
